Table 5 Regression analysis of individual trans fatty acids
Fatty acids | TC | TG | HDL | TC/HDL | LDL | Apo A1 | Apo B | hs CRP |
|---|---|---|---|---|---|---|---|---|
C16:1 trans | ||||||||
β Unadjusted (95% CI) | 5.1 (− 8.5, 18.7) | 26.5 (− 0.9, 53.8) | − 2.2 (− 6.3, 1.9) | 0.3 (− 0.2, 0.7) | 10.6 (− 4.3, 25.4) | − 1.6 (− 14.0, 10.7) | 10.1 (− 0.2, 20.4) | − 1.1 (− 5.3, 3.1) |
β Adjusted (95% CI)# | 3.4 (− 7.1, 13.9) | 20.9 (1.1, 40.7)* | − 0.4 (− 3.3, 2.5) | 0.1 (− 0.2, 0.4) | 0.7 (− 9.4, 10.8) | 0.2 (− 8.0, 8.4) | 2.6 (− 4.5, 9.7) | − 0.3 (− 3.4, 2.7) |
C18:1 11 trans (Vaccenic acid) | ||||||||
β Unadjusted (95% CI) | − 22.1 (− 55.4, 11.2) | 33.3 (− 34.5, 101.1) | − 0.4 (− 10.6, 9.7) | − 0.5 (− 1.6, 0.6) | − 21.1 (− 53.0, 10.8) | − 13 (− 39.4, 13.5) | − 7.6 (− 30.0, 14.7) | − 1.6 (− 10.7, 7.5) |
β Adjusted (95% CI)# | − 25.6 (− 72.3, 21.1) | 60.3 (− 34.1, 154.7) | 0.3 (− 13.4, 14.1) | − 0.8 (− 2.3, 0.7) | − 25.6 (− 69.0, 17.8) | − 16.5 (− 52.3, 19.3) | − 4.8 (− 35.3, 25.7) | − 4.9 (− 17.8, 8.0) |
C18:1 9 trans (Elaidic acid) | ||||||||
β Unadjusted (95% CI) | − 5.3 (− 22.8, 12.2) | 15.5 (− 20.1, 51.1) | − 2.8 (− 8.1, 2.5) | 0.2 (− 0.4, 0.7) | − 12 (− 29.7, 5.7) | 8.4 (− 6.3, 23.1) | − 8.3 (− 20.7, 4.0) | − 0.9 (− 6.0, 4.2) |
β Adjusted (95% CI)# | − 11.4 (− 38.6, 15.8) | 10.1 (− 45.1, 65.2) | − 5.2 (− 13.2, 2.8) | 0.2 (− 0.6, 1.1) | − 20.4 (− 48.0, 7.1) | 12.9 (− 9.8, 35.7) | − 14.4 (− 33.7, 4.9) | − 1.3 (− 9.5, 6.9) |